Cargando…

The Mechanism of Metabolic Influences on the Endogenous GLP-1 by Oral Antidiabetic Medications in Type 2 Diabetes Mellitus

Incretin-based therapy is now a prevalent treatment option for patients with type 2 diabetes mellitus (T2DM). It has been associated with considerably good results in the management of hyperglycemia with cardiac or nephron-benefits. For this reason, it is recommended for individuals with cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Thiquynhnga, Gong, Min, Wen, Song, Yuan, Xinlu, Wang, Chaoxun, Jin, Jianlan, Zhou, Ligang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320283/ https://www.ncbi.nlm.nih.gov/pubmed/32656265 http://dx.doi.org/10.1155/2020/4727390

Ejemplares similares

An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is)
por: Wen, Song, et al.
Publicado: (2021)

Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications
por: Gong, Min, et al.
Publicado: (2020)

Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice
por: Nguyen, Thiquynhnga, et al.
Publicado: (2020)

Low TSH Levels Within Euthyroid Range Could Play a Negative Role on Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes
por: Liu, Congying, et al.
Publicado: (2021)

Metabolic Effects on Body Components After a Three-Month Physical Intervention in Overweight Medical Staff
por: Wen, Song, et al.
Publicado: (2021)

The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot
por: Li, Xiucai, et al.
Publicado: (2023)

Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function
por: Kielgast, Urd, et al.
Publicado: (2011)

Is endogenous GLP-1 a major influence on the orbitofrontal cortex?
por: May, Aaron A., et al.
Publicado: (2015)

The Relationship between Serum Iron and Thyroid Function in the Patients with Type 2 Diabetes
por: Wang, Congcong, et al.
Publicado: (2023)

The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases
por: Wang, Chaoxun
Publicado: (2013)

Psoriasis Exacerbates the State of Insulin Resistance in Patients with Type 2 Diabetes
por: Wen, Song, et al.
Publicado: (2021)

Impact of oral antidiabetic agents on bone metabolism
por: Paul, Thomas V., et al.
Publicado: (2015)

Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men
por: Matikainen, Niina, et al.
Publicado: (2016)

Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
por: Kalogirou, Maria, et al.
Publicado: (2018)

Adherence to treatment for diabetes mellitus: validation of instruments for oral antidiabetics and insulin
por: Boas, Lilian Cristiane Gomes-Villas, et al.
Publicado: (2014)

Cardiovascular Safety of Oral Antidiabetic Medications: Need of the Hour
por: Kaduskar, Prashant Ulhas
Publicado: (2017)

Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
por: Jermendy, György, et al.
Publicado: (2012)

GIP Does Not Potentiate the Antidiabetic Effects of GLP-1 in Hyperglycemic Patients With Type 2 Diabetes
por: Mentis, Nikolaos, et al.
Publicado: (2011)

Reagents and models for detecting endogenous GLP1R and GIPR
por: Ast, Julia, et al.
Publicado: (2021)

Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism
por: Medak, Kyle D., et al.
Publicado: (2023)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects
por: Zhang, Hongkai, et al.
Publicado: (2015)

Novel Site-Specific Fatty Chain-Modified GLP-1 Receptor Agonist with Potent Antidiabetic Effects
por: Zhong, Xia, et al.
Publicado: (2019)

The Antidiabetic Mechanisms of Polyphenols Related to Increased Glucagon-Like Peptide-1 (GLP1) and Insulin Signaling
por: Domínguez Avila, J. Abraham, et al.
Publicado: (2017)

Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis
por: Nuhoho, Solomon, et al.
Publicado: (2019)

Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes
por: Salehi, Marzieh, et al.
Publicado: (2010)

Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets
por: HUANG, CHENGHU, et al.
Publicado: (2015)

An evaluation of the impact of antidiabetic medication on treatment satisfaction and quality of life in patients of diabetes mellitus
por: Chaturvedi, Richa, et al.
Publicado: (2018)

Insulin treatment in patients with diabetes mellitus and heart failure in the era of new antidiabetic medications
por: Staszewsky, Lidia, et al.
Publicado: (2022)

Concept for a Unidirectional Release Mucoadhesive Buccal Tablet for Oral Delivery of Antidiabetic Peptide Drugs Such as Insulin, Glucagon-like Peptide 1 (GLP-1), and their Analogs
por: Pratap-Singh, Anubhav, et al.
Publicado: (2023)

Antidiabetic effect of an engineered bacterium Lactobacillus plantarum-pMG36e -GLP-1 in monkey model
por: Luo, Jie, et al.
Publicado: (2021)

The impact of diabetes mellitus medication on the incidence of endogenous endophthalmitis
por: Chien, Ke-Hung, et al.
Publicado: (2020)

Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
por: Cheng, Chih-Ning, et al.
Publicado: (2020)

Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident Diabetes
por: Gatwood, Justin D., et al.
Publicado: (2018)

Nonglycemic Outcomes of Antidiabetic Medications
por: Morse, Christopher, et al.
Publicado: (2019)

Efficacy and Safety of Oral Antidiabetic Drugs in Comparison to Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis
por: Poolsup, Nalinee, et al.
Publicado: (2014)

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus
por: Seino, Yutaka, et al.
Publicado: (2015)

Influence of antidiabetic medications on predictive aptitude of TyG index for HFpEF
por: Shimoda, Tomonari, et al.
Publicado: (2023)

Understanding the influence of ethnicity on adherence to antidiabetic medication: Meta-ethnography and systematic review
por: Asiri, Rayah, et al.
Publicado: (2023)

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
por: Gundogdu, Evren, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q0gencogvipe39leovplu6a1mp